Related references
Note: Only part of the references are listed.Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
Maren Hermanns-Clausen et al.
ADDICTION (2013)
AKI Associated with Synthetic Cannabinoids: A Case Series
Gautam Kantilal Bhanushali et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201
David McQuade et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The Synthetic Cannabinoid Withdrawal Syndrome
Nicholas Nacca et al.
JOURNAL OF ADDICTION MEDICINE (2013)
Blood Synthetic Cannabinoid Concentrations in Cases of Suspected Impaired Driving
Jillian K. Yeakel et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2013)
SYNTHETIC CANNABINOID INTOXICATION: A CASE SERIES AND REVIEW
Carson R. Harris et al.
JOURNAL OF EMERGENCY MEDICINE (2013)
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism
Melanie Hutter et al.
JOURNAL OF MASS SPECTROMETRY (2013)
Ischemic stroke after use of the synthetic marijuana spice
Melissa J. Freeman et al.
NEUROLOGY (2013)
A Characterization of Synthetic Cannabinoid Exposures Reported to the National Poison Data System in 2010
Christopher O. Hoyte et al.
ANNALS OF EMERGENCY MEDICINE (2012)
RISKY RECREATION Synthetic Cannabinoids Have Dangerous Effects
Teena M. McGuinness et al.
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2012)
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Arshid Mir et al.
PEDIATRICS (2011)
Share Paper
